Latest news
HERTHENA-Breast02 Trial: Innovative Dual-ADC Strategy in HR+/HER2-Low Breast Cancer - OncodailyOncodaily · Sat, 08 Aug 2026 11:14:59 GMTUS Next Generation Drug Conjugates Market Size, Share,Trends, Growth Analysis Report, 2031 - MarketsandMarketsMarketsandMarkets · Thu, 06 Aug 2026 21:03:03 GMTOverfeeding cancer to stunt its growth - Drug Discovery NewsDrug Discovery News · Thu, 06 Aug 2026 13:46:00 GMTRapid Expansion Of Peptide And Nanobody Drug Conjugates - Clinical LeaderClinical Leader · Thu, 06 Aug 2026 05:19:56 GMTExperimental drug turns cancer's favorite fuel against it - Phys.orgPhys.org · Wed, 05 Aug 2026 22:20:06 GMTFDA-Approved ADCs Prompt the Need for Revisions to the Breast Cancer Management Road Map - OncLiveOncLive · Wed, 05 Aug 2026 20:23:21 GMTWhat FDA’s 2026 Draft Guidance Means for Antibody Drug Conjugates - Chromatography OnlineChromatography Online · Wed, 05 Aug 2026 17:24:33 GMTFraming the Evolving Bioconjugate Landscape - Chromatography OnlineChromatography Online · Wed, 05 Aug 2026 16:06:49 GMT